tizanidine hydrochloride
- Product NDC
- 71610-114
- 11-digit product format
- 716100114
- Labeler code
- 71610
- Product ID
- 71610-114_8826f454-0316-4981-8c28-9bf20cf956f8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076280
- Marketing category
- ANDA
- Marketing start
- 2002-06-27
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-114 | TIZANIDINE HYDROCHLORIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20180831_2d354fee-9440-4d56-8990-fe1dcc2305fc.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-114-30 | 71610011430 | 30 TABLET in 1 BOTTLE (71610-114-30) | 30 tablet | 2018-08-09 | 0000-00-00 | No | No | Current |
| 71610-114-53 | 71610011453 | 60 TABLET in 1 BOTTLE (71610-114-53) | 60 tablet | 2018-08-09 | 0000-00-00 | No | No | Current |
| 71610-114-60 | 71610011460 | 90 TABLET in 1 BOTTLE (71610-114-60) | 90 tablet | 2018-08-09 | 0000-00-00 | No | No | Current |